(InSilico Medicine, Inc.) The Cancer Biomarkers Data Commons Meeting (CBDC) Think Tank Meeting will be held at the National Cancer Institute from Feb 8 to 9th, 2018. The Think Tank Meeting will bring together thought leaders from academia, industry, and government to discuss approaches to the development of cancer biomarkers. Alex Zhavoronkov, CEO of Insilico Medicine, will present the advances in deep-learned multimodal biomarkers of aging at the meeting.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2FRMckr
No comments:
Post a Comment